Latest news

Thumbnail image for Just 55% of healthcare professionals disclosing pharma payments

Just 55% of healthcare professionals disclosing pharma payments

Only 55 percent of healthcare professionals receiving a payment or benefit in kind from the pharmaceutical industry in 2015 gave their consent for their details to be published on Disclosure UK, a new analysis by research organisation RAND Europe has revealed.

28th March 2017

Thumbnail image for Allergan reports success in late-stage acne trials

Allergan reports success in late-stage acne trials

Dublin, Ireland-based drugmaker Allergan and US partner Paratek Pharmaceuticals have reported that two Phase III trials assessing sarecycline for the treatment of moderate to severe acne have hit their primary endpoints.

28th March 2017

Thumbnail image for NHS England plans cull of ‘low-value’ prescriptions

NHS England plans cull of ‘low-value’ prescriptions

“Low-value” prescriptions such as sun cream and gluten-free foods may soon no longer be available on the National Health Service in England, after NHS England announced a review into whether they should continue to be funded by the health service.

28th March 2017

Thumbnail image for Patients call for halt to NICE changes

Patients call for halt to NICE changes

A coalition of almost 200 patient groups representing families affected by rare and genetic conditions have called for a halt to planned changes in the way therapies are appraised for NHS use, as they “threaten patients’ ability to access treatment, and work against the government's goal of accelerating access to innovative medicines”.

28th March 2017

Thumbnail image for Entries for Sales Manager of the Year are open

Entries for Sales Manager of the Year are open

Delivering meaningful recognition through high quality feedback, the PharmaTimes Sales Awards recognises and rewards outstanding sales representatives, managers and teams.

28th March 2017

Thumbnail image for Six new medicines backed for EU approval

Six new medicines backed for EU approval

Six new medicines, including three orphan drugs for rare diseases, have been backed for European Union approval by the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP).

27th March 2017

Thumbnail image for Pfizer bags approval for RA drug Xeljanz

Pfizer bags approval for RA drug Xeljanz

Some patients with moderate to severe forms of rheumatoid arthritis could get access to a new treatment option in Europe following the approval of Pfizer’s oral Janus kinase (JAK) inhibitor Xeljanz.

27th March 2017

Thumbnail image for Shire’s rare blood disorder drug gets US fast track

Shire’s rare blood disorder drug gets US fast track

An experimental therapy in development by Shire for patients with the rare blood disorder hereditary thrombotic thrombocytopenic purpura (hTTP) has been granted a fast track designation by the US Food and Drug Administration.

23rd March 2017

Thumbnail image for Three-quarters of CCGs failing to improve child mental health

Three-quarters of CCGs failing to improve child mental health

Almost three-quarters (73.2 percent) of local Clinical Commissioning Groups are failing to meet NHS England targets for improving children and young people’s mental health services (CAMHS), shows a new analysis by the Education Policy Institute.

23rd March 2017

Thumbnail image for NHS trusts under growing pressure to make savings

NHS trusts under growing pressure to make savings

Trusts are grappling with growing pressure from the top to increase savings in the approaching financial year, a survey by NHS Providers has revealed, just as three more are placed in financial special measures by the Care Quality Commission.

23rd March 2017

Previous  --   1 2 3 4 5 6 7 8 9 10   --  Next

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download